Unknown

Dataset Information

0

Platinum-containing regimens for triple-negative metastatic breast cancer.

ABSTRACT:

SUBMITTER: Egger SJ 

PROVIDER: S-EPMC8092567 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Platinum-containing regimens for metastatic breast cancer.
| S-EPMC6481538 | biostudies-literature
Unknown Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression.
| S-EPMC3919882 | biostudies-literature
Unknown Comparison of capecitabine-based regimens with platinum-based regimens in Chinese triple-negative breast cancer patients with liver metastasis.
| S-EPMC7867954 | biostudies-literature
Unknown Trastuzumab-containing regimens for metastatic breast cancer.
| S-EPMC6464904 | biostudies-literature
Unknown A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients.
| S-EPMC8764855 | biostudies-literature
Unknown Survival, treatment regimens and medical costs of women newly diagnosed with metastatic triple-negative breast cancer.
| S-EPMC8760241 | biostudies-literature
Unknown A systematic review of taxane-containing regimens for metastatic breast cancer.
| S-EPMC2361568 | biostudies-other
Unknown Association of 17q22 Amplicon Via Cell-Free DNA With Platinum Chemotherapy Response in Metastatic Triple-Negative Breast Cancer.
| S-EPMC8624042 | biostudies-literature
Unknown Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer.
| S-EPMC7989121 | biostudies-literature
Unknown Checkpoint inhibitor therapy for metastatic triple-negative breast cancer.
| S-EPMC8184866 | biostudies-literature